Paper 08 - EXPRESSION OF EMERGING THERAPEUTIC TARGET B7-H3 IN SARCOMA - A MASS SPECTROMETRY-BASED PROTEOMIC ANALYSIS OF >1000 SARCOMA SAMPLES

Author(s)

• 

  Liz A. Connolly, MBChB FRACP

  Dr
  Children's Medical Research Institute
  Melbourne, Victoria, Australia

  Slides

Co-Author(s)

• DB

  Daniel Bucio-Noble, PHD

  Children's Medical Research Institute
  Sydney, New South Wales, Australia
• JK

  Jennifer Koh, PhD

  Children's Medical Research Institute
  Sydney, New South Wales, Australia
• ES

  Erin Sykes, PhD

  Children's Medical Research Institute
  Sydney, New South Wales, Australia
• NM

  Nicholas McNamee, BMed MMed FRACP

  CMRI - ProCan Oncology
  Westmead, New South Wales, Australia
• AS

  Ahilya Singh, PhD

  Children's Medical Research Institute
  Sydney, New South Wales, Australia
• AA

  Adel Aref, PhD

  Children's Medical Research Institute
  Sydney, New South Wales, Australia
• 

  Lylee Ye, -

  Biobank/Research Officer
  Chris O'Brien Lifehouse
  Sydney, New South Wales, Australia
• RK

  Rooshdiya Karim, MD

  A/Prof
  NSW Health Pathology
  Sydney, New South Wales, Australia
• FM

  Fiona Maclean, PhD

  Douglas Hanly Moir pathology
  Sydney, New South Wales, Australia
• 

  Vivek A. Bhadri, MA, MBBS, PhD, FRACP

  Medical Oncologist
  Chris O’Brien Lifehouse
  Campertown, New South Wales, Australia
• 

  Elise F. Nassif Haddad, MD, PhD

  Assistant Professor
  MD Anderson Cancer Center
  Houston, Texas, United States
• DI

  Davis R. Ingram, BS

  Sr Research Assistant
  MD Anderson Cancer Center
  Houston, Texas, United States
• RM

  Rohini R Morey, n/a

  MD Anderson Cancer Center
  Houston, Texas, United States
• KW

  Khalida M. Wani, PhD

  Manager
  MD Anderson Cancer Center
  Houston, Texas, United States
• 

  Alexander J. Lazar, MD, PhD (he/him/his)

  Professor of Pathology & Genomic Medicine
  MD Anderson Cancer Center
  Houston, Texas, United States
• 

  David Thomas, FRACP, PhD (he/him/his)

  Director
  Centre for Molecular Oncology
  Sydney, New South Wales, Australia
• 

  Mandy Ballinger, BSc, PhD, MGenCouns (she/her/hers)

  Deputy Director
  Centre for Molecular Oncology
  Sydney, New South Wales, Australia
• JS

  John Simes, BSc (Med) MBBS, FRACP, MD

  Co-director
  NHMRC Clinical Trials Centre (CTC)
  Sydney, New South Wales, Australia
• CS

  Clare Scott, MBBS PHD

  Walter and Eliza Hall Institute of Medical Research
  Melbourne, Victoria, Australia
• HB

  Holly E. Barker, BA BSc(Hons) PhD

  The Walter and Eliza Hall Institute of Medical Research
  Melbourne, Victoria, Australia
• BM

  Briony Milesi, PhD

  The Walter and Eliza Hall Institute of Medical Research
  Melbourne, Victoria, Australia
• GR

  Gayanie Ratnayake, FRCPA

  The Royal Children's Hospital
  Melbourne, Victoria, Australia
• 

  Jason E. Cain, PhD

  Research Group Head
  Hudson Institute of Medical Research
  Clayton, Victoria, Australia
• NZ

  Nataliya Zhukova, MBBS

  Hudson Institute of Medical Research
  Melbourne, Victoria, Australia
• PH

  Peter Hains, BSc Hons, PhD

  CMRI
  Sydney, New South Wales, Australia
• LH

  Lisa Horvath, MD PhD FRACP

  Chris O'Brien Lifehouse
  Sydney, New South Wales, Australia
• 

  Peter S. Grimison, FRACP PhD

  Staff Specialist in Medical Oncology and Director of Physician Training
  Chris O'Brien Lifehouse
  Sydney, New South Wales, Australia
• PR

  Phil Robinson, PhD

  Co-Director
  ProCan, Children's Medical Research Institute
  Sydney, New South Wales, Australia
• 

  Roger Reddel, MBBS/PhD/FRACP

  Executive Director
  Children's Medical Research Institute, The University of Sydney
  Westmead, New South Wales, Australia